Results 111 to 120 of about 46,924 (216)
VaxGen is developing prophylactic vaccines against HIV-1 consisting of two recombinant gp120 surface proteins from different HIV-1 strains.This profile has been selected from R&D Insight, a pharmaceutical intelligence database produced by Adis International Ltd.
openaire +2 more sources
MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I-ASSOCIATED VACCINE PROTECTION FROM SIMIAN IMMUNODEFICIENCY VIRUS-INFECTED PERIPHERAL-BLOOD CELLS [PDF]
Boes, J +14 more
core +1 more source
Antiretroviral effect of 4-thio-uridylate against human immunodeficiency virus type 1 [PDF]
Albert J. +32 more
core +1 more source
Galectin-8 binds HIV envelope glycoproteins with high affinity and promotes viral infectivity. [PDF]
Sheik-Khalil E +6 more
europepmc +1 more source
HIV gp120 induces TREM1 expression through TLR-PGE₂ signalling in human monocyte-derived microglia. [PDF]
Mahama A +4 more
europepmc +1 more source

